Effect of spironolactone and potassium canrenoate on cytosolic and nuclear androgen and estrogen receptors of rat liver.

[1]  D. V. van Thiel,et al.  Hepatic estrogen receptor in human liver disease. , 1987, Gastroenterology.

[2]  D. V. van Thiel,et al.  Sex hormone-related functions in regenerating male rat liver. , 1986, Gastroenterology.

[3]  P. Eagon,et al.  A male specific hepatic estrogen binding protein: characteristics and binding properties. , 1986, Archives of biochemistry and biophysics.

[4]  D. V. van Thiel,et al.  Circadian rhythm of hepatic cytosolic and nuclear estrogen and androgen receptors. , 1986, Gastroenterology.

[5]  G. Idéo,et al.  GYNAECOMASTIA AFTER SPIRONOLACTONE AND POTASSIUM CANRENOATE , 1986, The Lancet.

[6]  G. Farrell,et al.  Effects of portal vein ligation on sex hormone metabolism in male rats: relationship to lowered hepatic cytochrome P450 levels. , 1986, Gastroenterology.

[7]  P. Eagon,et al.  Effects of H2-antagonists on androgen imprinting of male hepatic functions. , 1985, Endocrinology.

[8]  M. Losowsky,et al.  IDENTIFICATION AND CHARACTERIZATION OF THE HUMAN HEPATIC ANDROGEN RECEPTOR , 1985, Clinical endocrinology.

[9]  A. Dupont.  DISAPPEARANCE OF SPIRONOLACTONE-INDUCED GYNAECOMASTIA DURING TREATMENT WITH POTASSIUM CANRENOATE , 1985, The Lancet.

[10]  R. Lobo,et al.  The effect of spironolactone on genital skin 5α-reductase activity , 1985 .

[11]  D. V. van Thiel,et al.  Estrogen and Androgen Receptors in Liver: Their Role in Liver Disease and Regeneration , 1985, Seminars in liver disease.

[12]  C. Niewoehner,et al.  Gynecomastia in a hospitalized male population. , 1984, The American journal of medicine.

[13]  D. V. van Thiel,et al.  Regenerating rat liver: correlations between estrogen receptor localization and deoxyribonucleic acid synthesis. , 1984, Gastroenterology.

[14]  D. V. van Thiel,et al.  Alcohol-induced changes in hepatic estrogen-binding proteins: a mechanism explaining feminization in alcoholics. , 1981, Archives of biochemistry and biophysics.

[15]  J. Gustafsson,et al.  Multihormonal regulation of the estrogen receptor in rat liver. , 1981, Endocrinology.

[16]  B. Katzenellenbogen,et al.  Comparative effects of estrogen and antiestrogen on plasma renin substrate levels and hepatic estrogen receptors in the rat. , 1981, Endocrinology.

[17]  D. V. van Thiel,et al.  Estrogen-binding proteins of male rat liver: influences of hormonal changes. , 1980, Archives of biochemistry and biophysics.

[18]  G. Lucier,et al.  Sex differences in estrogen binding by cytosolic and nuclear components of rat liver. , 1980, Journal of steroid biochemistry.

[19]  D. V. van Thiel,et al.  Alcohol-induced testicular atrophy in the adult male rat. , 1979, Endocrinology.

[20]  R. Tremblay,et al.  New therapeutic approach to the hirsute patient. , 1979, Fertility and sterility.

[21]  R. Dickson,et al.  Estrogen receptor in adult male rat liver. , 1978, Endocrinology.

[22]  C. Hignite,et al.  Gynecomastia induced in normal males by spironolactone , 1978, Clinical pharmacology and therapeutics.

[23]  M. Duffy,et al.  Estradiol receptors in human liver. , 1978, Journal of steroid biochemistry.

[24]  R. Vigersky,et al.  Interaction of digitalis and spironolactone with human sex steroid receptors. , 1978, The Journal of clinical endocrinology and metabolism.

[25]  J. C. Pita,et al.  Spironolactone and endocrine dysfunction. , 1976, Annals of internal medicine.

[26]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[27]  J. Gillette,et al.  Spironolactone and testicular cytochrome P-450: decreased testosterone formation in several species and changes in hepatic drug metabolism. , 1974, Endocrinology.

[28]  D. Greenblatt,et al.  Adverse Reactions to Spironolactone , 1973 .

[29]  F. Greenway,et al.  Estrogen-androgen imbalance in hepatic cirrhosis. Studies in 13 male patients. , 1973, Annals of internal medicine.

[30]  D. Greenblatt,et al.  Adverse reactions to spironolactone. A report from the Boston Collaborative Drug Surveillance Program. , 1973, JAMA.

[31]  E. Clark.  SPIRONOLACTONE THERAPY AND GYNECOMASTIA. , 1965, JAMA.

[32]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[33]  D. V. van Thiel,et al.  Characterization and quantitation of human hepatic estrogen receptor. , 1983, Gastroenterology.

[34]  J. Gustafsson,et al.  Sex steroid induced changes in hepatic enzymes. , 1983, Annual review of physiology.

[35]  A. Karbowiak,et al.  Second international congress of hormones and cancer21 Antiandrogenic effect and plasma androgen-receptor activity in mouse during treatment with spironolactone and potassium canrenoate , 1983 .

[36]  T. Hökfelt,et al.  CHAPTER 2 – The Hypothalamo–Pituitary–Liver Axis: A New Hormonal System in Control of Hepatic Steroid and Drug Metabolism , 1980 .

[37]  K. Burton.  [105] Determination of DNA concentration with diphenylamine , 1968 .